Y
Yong Park
Researcher at Korea University
Publications - 138
Citations - 1600
Yong Park is an academic researcher from Korea University. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Multiple myeloma. The author has an hindex of 17, co-authored 133 publications receiving 1114 citations.
Papers
More filters
Journal ArticleDOI
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim,Dok Hyun Yoon,Arnaud Jaccard,Wee Joo Chng,Soon Thye Lim,Huangming Hong,Yong Park,Kian Meng Chang,Yoshinobu Maeda,Fumihiro Ishida,Dong Yeop Shin,Jin Seok Kim,Seong Hyun Jeong,Deok Hwan Yang,Jae Cheol Jo,Gyeong Won Lee,Chul Won Choi,Won Sik Lee,Tsai Yun Chen,Kiyeun Kim,Sin-Ho Jung,Tohru Murayama,Yasuhiro Oki,Ranjana H. Advani,Francesco d'Amore,Norbert Schmitz,Cheolwon Suh,Ritsuro Suzuki,Yok-Lam Kwong,Tong Yu Lin,Won Seog Kim +30 more
TL;DR: A retrospective study of patients with newly diagnosed ENKTL without any previous treatment history for the disease who were given non-anthracycline-based chemotherapies with or without upfront concurrent chemoradiotherapy or radiotherapy with curative intent showed that age greater than 60 years, stage III or IV disease, distant lymph-node involvement, and non-nasal type disease were significantly associated with overall survival and progression-free survival.
Journal ArticleDOI
Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes.
Hyunku Shin,Seunghyun Oh,Soonwoo Hong,Min-Sung Kang,Daehyeon Kang,Yong-gu Ji,Byeong Hyeon Choi,Ka-Won Kang,Hyesun Jeong,Yong Park,Sunghoi Hong,Hyun Koo Kim,Yeonho Choi +12 more
TL;DR: An accurate diagnosis of early-stage lung cancer is demonstrated, using deep learning-based surface-enhanced Raman spectroscopy of the exosomes of cells derived from normal and lung cancer cell lines, with an accuracy of 95%.
Journal ArticleDOI
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Yu Ri Kim,Jin Seok Kim,Yoo Hong Min,Dok Hyunyoon,Ho Jin Shin,Yeung-Chul Mun,Yong Park,Young Rok Do,Seong Hyun Jeong,Joon Seong Park,Sung Yong Oh,Suee Lee,Eunkyung Park,Joung Soon Jang,Won Sik Lee,Hwe Won Lee,Hyeon-Seok Eom,Jae Sook Ahn,Jae Heon Jeong,Sun Kyung Baek,Seok Jin Kim,Won Seog Kim,Cheolwon Suh +22 more
TL;DR: Data suggests that outcomes of primary adrenal DLBCL are encouraging using a regimen of R-CHOP, and that achieving CR after R- CHOP is predictive of survival, and the modified staging system may have prognostic value.
Journal ArticleDOI
Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma
Ho-Young Yhim,Jin Seok Kim,Yeung-Chul Mun,Joon Ho Moon,Yee Soo Chae,Yong Park,Jae Cheol Jo,Seok Jin Kim,Dok Hyun Yoon,June-Won Cheong,Jae Yong Kwak,Je-Jung Lee,Won Seog Kim,Cheolwon Suh,Deok Hwan Yang +14 more
TL;DR: Multivariate analysis showed NKPI and pretransplant response were independent prognostic factors influencing survival, particularly NKPI in limited disease and prettransplant response in advanced disease.
Journal ArticleDOI
The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer.
Yong Park,Jee Won Kim,Dae Sik Kim,Eui Bae Kim,Se Jong Park,Jin Yong Park,Woo Suk Choi,Jong Gyu Song,Hee Yun Seo,Sang Cheul Oh,Byung Soo Kim,Jong Jae Park,Yeul Hong Kim,Jun Suk Kim +13 more
TL;DR: BMP-2 seems to have a role in progression to metastatic disease in gastric cancer, especially in the late stage of tumorigenesis, including invasion and metastasis.